"Researchers testing repurposed drugs against Covid-19 found that ivermectin didn't reduce hospital admissions, in the largest trial yet of the effect of the antiparasitic on the disease driving the pandemic," reports the Wall Street Journal:
Public-health authorities and researchers have for months said the drug hasn't shown any benefit in treating the disease.... The latest trial, of nearly 1,400 Covid-19 patients at risk of severe disease, is the largest to show that those who received ivermectin as a treatment didn't fare better than those who received a placebo. "There was no indication that ivermectin is clinically useful," said Edward Mills, one of the study's lead researchers and a professor of health sciences at Canada's McMaster University in Hamilton, Ontario. The New York Daily News reports that the FDA claims thativermectin showed no benefits in clinical testing and could be dangerous in large doses.
According to Seeking Alpha, these new findings have been accepted for publication in a major peer-reviewed medical journal.
